apl. Prof. Dr. Beatrice Schuler-Thurner

Medizinische Fakultät

GMP-compliant human monocyte-derived dendritic cells for cancer vaccination generated by using the Quantum (R) hollow fiber bioreactor system (2019) Uslu U, Uslu U, Erdmann M, Wiesinger M, Schuler G, Schuler-Thurner B Conference contribution Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. (2019) Wiesinger M, Maerz J, Kummer M, Schuler G, Dörrie J, Schuler-Thurner B, Schaft N Journal article Blood eosinophilia is an on-treatment biomarker in patients undergoing vaccination with dendritic cells that correlates with long-term patient outcome (2019) Moreira A, Vass V, Erdmann M, Sponagl F, Schuler G, Schuler-Thurner B Conference contribution Vaccination with dendritic Cells for metastasized Uveal Melanoma: immunological and clinical Responses (2019) Moreira A, Gross S, Uslu U, Dörrie J, Kummer M, Schliep S, Sponagl F, et al. Conference contribution Arming T cells with a gp100-specific TCR and a CSPG4-specific CAR using combined DNA-and RNA-based receptor transfer (2019) Simon B, Harrer DC, Schuler-Thurner B, Schuler G, Uslu U Journal article The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy (2019) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Automated Good Manufacturing Practice–compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines (2019) Uslu U, Erdmann M, Wiesinger M, Schuler G, Schuler-Thurner B Journal article Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy (2019) Simon B, Harrer DC, Thirion C, Schuler-Thurner B, Schuler G, Uslu U Journal article The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U Journal article Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy (2018) Erdmann M, Uslu U, Wiesinger M, Bruening M, Altmann T, Strasser E, Schuler G, Schuler-Thurner B Journal article